408 related articles for article (PubMed ID: 15237721)
1. [HIV associated encephalopathy after highly active antiretroviral therapy (HAART)].
Kishida S
No To Shinkei; 2004 Apr; 56(4):301-10. PubMed ID: 15237721
[No Abstract] [Full Text] [Related]
2. An emerging severe leukoencephalopathy: is it due to HIV disease or highly active antiretroviral therapy?
Rackstraw S; Meadway J; Bingham J; Al-Sarraj S; Everall I
Int J STD AIDS; 2006 Mar; 17(3):205-7. PubMed ID: 16510013
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 associated dementia: symptoms and causes.
Ghafouri M; Amini S; Khalili K; Sawaya BE
Retrovirology; 2006 May; 3():28. PubMed ID: 16712719
[TBL] [Abstract][Full Text] [Related]
4. Neuropathology and neurodegeneration in HIV infection.
Jellinger KA
Clin Neuropathol; 2001; 20(6):276-7. PubMed ID: 11758784
[No Abstract] [Full Text] [Related]
5. HIV infection and dementia in older adults.
Valcour V; Paul R
Clin Infect Dis; 2006 May; 42(10):1449-54. PubMed ID: 16619159
[TBL] [Abstract][Full Text] [Related]
6. HIV and direct damage of organs: disease spectrum before and during the highly active antiretroviral therapy era.
Moroni M; Antinori S
AIDS; 2003 Apr; 17 Suppl 1():S51-64. PubMed ID: 12870531
[TBL] [Abstract][Full Text] [Related]
7. [Neurologic complications of HIV infection in the HAART era. Rapid and efficient diagnosis].
Arendt G; Haslinger BA
MMW Fortschr Med; 2003 Apr; 145 Spec No 1():66-9. PubMed ID: 15011596
[TBL] [Abstract][Full Text] [Related]
8. Impact of current antiretroviral therapies on neuroAIDS.
Vivithanaporn P; Gill MJ; Power C
Expert Rev Anti Infect Ther; 2011 Apr; 9(4):371-4. PubMed ID: 21504390
[No Abstract] [Full Text] [Related]
9. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
[TBL] [Abstract][Full Text] [Related]
10. Immune reconstitution inflammatory syndrome manifesting as disseminated tuberculosis, deep venous thrombosis, encephalopathy and myelopathy.
Tahir M; Sinha S; Sharma SK; Mitsuyasu RT
Indian J Chest Dis Allied Sci; 2008; 50(4):363-4. PubMed ID: 19035057
[TBL] [Abstract][Full Text] [Related]
11. Highly active antiretroviral therapy and human immunodeficiency virus encephalitis.
Cook JE; Dasgupta S; Middaugh LD; Terry EC; Gorry PR; Wesselingh SL; Tyor WR
Ann Neurol; 2005 Jun; 57(6):795-803. PubMed ID: 15852478
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
[TBL] [Abstract][Full Text] [Related]
13. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
14. [Neurological manifestations of HIV-infection in the era of highly active antiretroviral therapy (HAART)].
Arendt G
Fortschr Neurol Psychiatr; 2005 Oct; 73(10):577-86. PubMed ID: 16217698
[TBL] [Abstract][Full Text] [Related]
15. [Award of the 2003 AIDS Prize. Why doesn HAART therapy induce lipodystrophy in HIV positive patients?].
HNO; 2003 Jul; 51(7):543. PubMed ID: 12916494
[No Abstract] [Full Text] [Related]
16. Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002-2004.
Donoghoe MC; Bollerup AR; Lazarus JV; Nielsen S; Matic S
Int J Drug Policy; 2007 Aug; 18(4):271-80. PubMed ID: 17689375
[TBL] [Abstract][Full Text] [Related]
17. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
[TBL] [Abstract][Full Text] [Related]
18. Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments.
Gray F; Adle-Biassette H; Chretien F; Lorin de la Grandmaison G; Force G; Keohane C
Clin Neuropathol; 2001; 20(4):146-55. PubMed ID: 11495003
[TBL] [Abstract][Full Text] [Related]
19. Oral lesions and immune reconstitution syndrome in HIV+/AIDS patients receiving highly active antiretroviral therapy. Epidemiological evidence.
Gaitan Cepeda LA; Ceballos Salobreña A; López Ortega K; Arzate Mora N; Jiménez Soriano Y
Med Oral Patol Oral Cir Bucal; 2008 Feb; 13(2):E85-93. PubMed ID: 18223535
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.
Antinori A; Larussa D; Cingolani A; Lorenzini P; Bossolasco S; Finazzi MG; Bongiovanni M; Guaraldi G; Grisetti S; Vigo B; Gigli B; Mariano A; Dalle Nogare ER; De Marco M; Moretti F; Corsi P; Abrescia N; Rellecati P; Castagna A; Mussini C; Ammassari A; Cinque P; d'Arminio Monforte A;
Clin Infect Dis; 2004 Dec; 39(11):1681-91. PubMed ID: 15578371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
